Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check5 days agoChange DetectedAdded a new revision entry for Revision v3.4.3 and removed Revision v3.4.2 on the Record History page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, indicating a new page version. The older funding notice and Revision: v3.4.1 were removed, reflecting routine maintenance of the record history.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a government funding/status notice banner and updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedUI and metadata enhancements include a 'Show glossary' option, a new color-coding legend for additions and deletions, and an updated revision banner showing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check62 days agoChange DetectedA new revision label v3.3.4 was added and the previous v3.3.3 revision was removed from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page footer now shows a new revision label: Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 label have been removed from the footer.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.